Moore Capital Management LP Has $17.27 Million Holdings in UnitedHealth Group Incorporated $UNH

Moore Capital Management LP reduced its holdings in UnitedHealth Group Incorporated (NYSE:UNH) by 35.4% in the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 50,000 shares of the healthcare conglomerate’s stock after selling 27,388 shares during the period. Moore Capital Management LP’s holdings in UnitedHealth Group were worth $17,265,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors have also recently added to or reduced their stakes in the company. Sagard Holdings Management Inc. bought a new stake in shares of UnitedHealth Group in the second quarter valued at approximately $29,000. Foster Dykema Cabot & Partners LLC grew its position in UnitedHealth Group by 69.4% in the 3rd quarter. Foster Dykema Cabot & Partners LLC now owns 83 shares of the healthcare conglomerate’s stock worth $29,000 after purchasing an additional 34 shares during the last quarter. 1248 Management LLC acquired a new stake in UnitedHealth Group during the third quarter worth about $29,000. Hurley Capital LLC raised its holdings in UnitedHealth Group by 81.6% in the 3rd quarter. Hurley Capital LLC now owns 89 shares of the healthcare conglomerate’s stock valued at $31,000 after acquiring an additional 40 shares in the last quarter. Finally, Cloud Capital Management LLC acquired a new stake in shares of UnitedHealth Group during the 3rd quarter worth approximately $32,000. Institutional investors own 87.86% of the company’s stock.

UnitedHealth Group Stock Up 1.2%

Shares of NYSE:UNH opened at $285.55 on Tuesday. UnitedHealth Group Incorporated has a one year low of $234.60 and a one year high of $606.36. The stock has a market cap of $259.19 billion, a price-to-earnings ratio of 21.65, a P/E/G ratio of 1.30 and a beta of 0.41. The company has a debt-to-equity ratio of 0.72, a current ratio of 0.79 and a quick ratio of 0.79. The company has a 50 day moving average of $302.22 and a 200-day moving average of $325.14.

UnitedHealth Group (NYSE:UNH) last released its earnings results on Tuesday, January 27th. The healthcare conglomerate reported $2.11 EPS for the quarter, topping analysts’ consensus estimates of $2.09 by $0.02. The firm had revenue of $113.73 billion during the quarter, compared to analyst estimates of $113.38 billion. UnitedHealth Group had a net margin of 2.69% and a return on equity of 14.79%. The business’s quarterly revenue was up 12.3% compared to the same quarter last year. During the same quarter in the previous year, the business earned $6.81 EPS. UnitedHealth Group has set its FY 2026 guidance at 17.750- EPS. On average, sell-side analysts forecast that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current year.

UnitedHealth Group Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Tuesday, March 17th. Shareholders of record on Monday, March 9th will be paid a $2.21 dividend. The ex-dividend date of this dividend is Monday, March 9th. This represents a $8.84 annualized dividend and a yield of 3.1%. UnitedHealth Group’s dividend payout ratio is presently 67.02%.

Analyst Ratings Changes

Several brokerages recently commented on UNH. Morgan Stanley reduced their target price on UnitedHealth Group from $411.00 to $409.00 and set an “overweight” rating for the company in a research report on Friday, January 23rd. UBS Group reduced their price objective on shares of UnitedHealth Group from $430.00 to $410.00 and set a “buy” rating for the company in a report on Wednesday, January 28th. Barclays lowered their target price on shares of UnitedHealth Group from $391.00 to $327.00 and set an “overweight” rating on the stock in a research note on Friday, January 30th. Leerink Partners decreased their price objective on UnitedHealth Group from $410.00 to $345.00 and set an “outperform” rating on the stock in a report on Wednesday, January 28th. Finally, Weiss Ratings cut UnitedHealth Group from a “hold (c-)” rating to a “sell (d+)” rating in a report on Monday, March 2nd. One research analyst has rated the stock with a Strong Buy rating, seventeen have given a Buy rating, eight have given a Hold rating and two have assigned a Sell rating to the stock. According to MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and an average price target of $372.13.

Trending Headlines about UnitedHealth Group

Here are the key news stories impacting UnitedHealth Group this week:

• Positive Sentiment: Analyst bullish case: A Seeking Alpha piece argues UNH is a buy, citing attractive valuation, management’s focus on efficiency, and targeted AI-driven cost savings (~$1B) plus 2026 guidance (EPS > $17.75, revenue ~ $439B) that support a turnaround thesis. UnitedHealth: Why AI Is The Secret Weapon For The Turnaround
• Positive Sentiment: Product expansion: UnitedHealthcare expanded its doula support nationwide for employer plans — a growth/benefit initiative that can improve maternal outcomes and strengthen commercial plan stickiness. This is a near-term product win that supports revenue diversification and member engagement. UnitedHealthcare Expands Doula Offering to Employer-Sponsored Plans Nationwide
• Neutral Sentiment: Bull summaries / investor letters: Two market writeups reiterate a bullish long-term view based on valuation and earnings power, arguing current multiples present a buying opportunity for longer-term investors — useful context but not new company-level catalysts. Is UnitedHealth Group Incorporated (UNH) A Good Stock To Buy Now? Is UnitedHealth Group Incorporated (UNH) A Good Stock To Buy Now?
• Neutral Sentiment: Leadership and margin-repair narrative: Appointing Dennis Stankiewicz as Chief Accounting Officer and conference presentations signal governance and messaging steps as UNH works through 2025 headwinds; these are supportive but execution-dependent. How Leadership Shifts and Margin Repair Efforts At UnitedHealth Group (UNH) Has Changed Its Investment Story
• Negative Sentiment: Analyst caution / valuation: A Seeking Alpha Hold note says UNH is stabilizing but not yet a buy — revenue/membership declines reflect strategic resets and valuation compression removes prior premium, suggesting limited margin of safety for new capital. UnitedHealth: Stabilizing, But Not Yet A Buy
• Negative Sentiment: Policy/regulatory risk: A Joint Economic Committee analysis found ~$13.4B in 2025 excess Medicare Advantage payments (about $212 per enrollee), a headline that fuels regulatory scrutiny and could pressure margins or future reimbursement structures. Seniors Overpaid Medicare Premiums By $13.4B In 2025…

UnitedHealth Group Company Profile

UnitedHealth Group Inc is a diversified health care company headquartered in Minnetonka, Minnesota, that operates two primary business platforms: UnitedHealthcare and Optum. Founded in 1977, the company provides a broad range of health benefits and health care services to individuals, employers, governmental entities and other organizations. Its operations span commercial employer-sponsored plans, individual and Medicare and Medicaid programs, and services for customers and health systems in the United States and selected international markets.

UnitedHealthcare is the company’s benefits business, administering health plans and networks, managing provider relationships, and offering coverage products for employers, individuals, and government-sponsored programs.